Abilify approved as adjunct for maintenance treatment of bipolar disorder - ONA
Links shared publicly online about this topic.
- 487total visits
Abilify approved as adjunct for maintenance treatment of bipolar disorder - ONA
View full resource at oncologynurseadvisor.com
Tags: Bipolar Disorder, Bipolar Disorder Medication, Schizophrenia Medication, Antipsychotic Medication, Disease and Condition, Abilify, Bristol-Myers Squibb
Most Recently Shared on February 22, 2011 at 7:15 pm By:
Abilify approved as adjunct for maintenance treatment of bipolar disorder http://goo.gl/fb/6ZuIk
A drug used for maintenance treatment of bipolar disorder lacks evidence, scientists contend - latimes.com
latimes.com — “Only one badly flawed study was used to support the approval of Abilify (aripiprazole) for the maintenance treatment of bipolar disorder, scientists contend in an analysis of the data” View full resource at latimes.com
Most Recently Shared on May 11, 2011 at 9:45 pm By:
RWJF Human Capital Health Organization
RWJF Hlth & Society Scholar Tsai's research casts doubt on long-term use of popular #bipolar disorder drug: http://ow.ly/4SqCO
A drug used for maintenance treatment of bipolar disorder lacks evidence, scientists contend - latimes.com
latimes.com — “Only one badly flawed study was used to support the approval of Abilify (aripiprazole) for the maintenance treatment of bipolar disorder, scientists contend in an analysis of the data” View full resource at latimes.com
Most Recently Shared on May 4, 2011 at 10:25 am By:
Timothy Lomauro Doctor, Psychologist, and PhD
A drug used for maintenance treatment of #bipolar disorder lacks evidence, scientists contend - latimes.com http://t.co/gf4DcOb #psych
ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium | Pharmainfo.net
pharmainfo.net — “ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium | Pharmainfo.net” View full resource at pharmainfo.net
Most Recently Shared on February 25, 2011 at 1:15 am By:
Peter H Brown Doctor and Psychologist
ABILIFY® (aripiprazole) Approved for Maintenance Treatment of ... http://bit.ly/hQ3HCe #bipolar
Abilify approved as adjunct for maintenance treatment of bipolar disorder - MPR
empr.com — “Bristol-Myers Squibb and Otsuka announced that Abilify (aripiprazole) has been approved by the FDA as an adjunct to lithium or valproate for the maintenance treatment of bipolar I disorder.” View full resource at empr.com
Most Recently Shared on February 22, 2011 at 8:04 pm By:
MPR News: Abilify approved as adjunct for maintenance treatment of bipolar disorder: Bristol-Myers Squibb and Ot... http://bit.ly/ffWVy7
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate
drugs.com — “Abilify (aripiprazole) is used to treat schizophrenia, Bipolar I Disorder, depression and irritability associated with autistic disorder. Includes Abilify side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 21, 2011 at 10:15 pm By:
Drugs and Devices OW OW Health
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Li... http://bit.ly/fuFJIk #drug
ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate - Business Wire - Wire - BradentonHerald.com
bradenton.com — “Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. , announced today that the U.S. Food and Drug Administration (FDA) has approved ABILIFY ® (aripiprazole) as an adjunct to the mood stabilizers lithium or valproate for the maintenance treatment of Bipolar I Disorder.” View full resource at bradenton.com
Most Recently Shared on February 17, 2011 at 5:02 pm By:
Peter H Brown Doctor and Psychologist
ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I ... http://bit.ly/fnyJ5i #bipolar
Saphris gains indications - MPR
empr.com — “Merck announced that Saphris (asenapine sublingual tablets) has been approved for two additional indications: 1) the maintenance treatment of schizophrenia and 2) as adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.” View full resource at empr.com
Most Recently Shared on January 25, 2011 at 7:25 pm By:
MPR News: Saphris gains indications: Merck announced that Saphris (asenapine sublingual tablets) has been approv... http://bit.ly/i8jUas
FDA Approves Asenapine Sublingual Tablets for Expanded Use in Schizophrenia, Bipolar Disorder - QualityPoint Technologies
qualitypointtech.net — “Merck announces FDA approval for expanded adult use of its asenapine sublingual tablets to now include maintenance treatment for schizophrenia and as adjunctive therapy for bipolar 1 disorder. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on September 14, 2010 at 9:36 pm By:
FDA Approves Asenapine Sublingual Tablets for Expanded Use in Schizophrenia, Bipolar Disorder: Merck announces FDA... http://bit.ly/9V6vFU
Pfizer Receives FDA Approval For Geodon (Ziprasidone HCl) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults
drugs.com — “Geodon (ziprasidone) is used for the Adjunctive Maintenance Treatment of Bipolar Disorder. Includes Geodon side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 23, 2009 at 11:39 pm By:
FDA Approves Geodon Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults - http://bit.ly/5k3r6q
Medical News: Ziprasidone Okayed for Bipolar Disorder - in Psychiatry, Bipolar Disorder from MedPage Today
medpagetoday.com — “The FDA has approved another antipsychotic agent -- ziprasidone (Geodon) -- for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate.” View full resource at medpagetoday.com
Most Recently Shared on November 23, 2009 at 4:40 pm By:
The FDA has cleared ziprasidone (Geodon) for adjunct maintenance treatment of bipolar I disorder. More: http://bit.ly/8glSps
Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults
medicalnewstoday.com — “Pfizer announced that the u.s. food and drug administration (fda) has approved geodon® (ziprasidone hci) capsules for maintenance treatment of bipolar i disorder as an adjunct to lithium or va” View full resource at medicalnewstoday.com
Most Recently Shared on November 23, 2009 at 3:39 pm By:
Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment .. http://bit.ly/07JCNcs
Geodon approved for adjunctive maintenance treatment of bipolar I disorder - MPR
empr.com — “The FDA has approved Geodon (ziprasidone HCl, from Pfizer) capsules for the maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults.” View full resource at empr.com
Most Recently Shared on November 20, 2009 at 10:14 pm By:
MPR News: Geodon approved for adjunctive maintenance treatment of bipolar I disorder: The FDA has approved Geodon (... http://bit.ly/7IlmwH
Advertisement
